Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:48 PM
NCT ID:
NCT02510794
Description:
Number of events includes all occurrences. Table summary includes adverse events that started or worsened (for existing condition) on or after the date of first study treatment during the study.
Frequency Threshold:
0.05
Time Frame:
Baseline up to approximately Month 38
Study:
NCT02510794
Study Brief:
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Event Groups(If Any):
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Intravitreal Injection With Ranibizumab 0.5mg | Participants received ranibizumab 0.5 mg monthly ITV injections of 10 mg/mL formulation at Day 1 and every month thereafter. | 1 | None | 4 | 41 | 35 | 41 | View |
| Port Delivery System With Ranibizumab 10mg/mL | Participants had the Implant (prefilled with approximately 20 μL of 10-mg/mL ,approximately 0.2 mg dose, of ranibizumab) surgically inserted in the study eye at the Day 1 visit following their randomization visit. Starting at the Month 1 visit, participants were evaluated monthly for the need for Implant refill with the 10-mg/mL formulation of ranibizumab according to their randomization as per protocol-specified refill criteria. | 1 | None | 14 | 58 | 57 | 58 | View |
| Port Delivery System With Ranibizumab 40mg/mL | Participants had the Implant (prefilled with approximately 20 μL of 40-mg/mL, approximately 0.8 mg dose, of ranibizumab) surgically inserted in the study eye at the Day 1 visit following their randomization visit. Starting at the Month 1 visit, participants were evaluated monthly for the need for Implant refill with the 40-mg/mL formulation of ranibizumab according to their randomization as per protocol-specified refill criteria. | 2 | None | 19 | 62 | 59 | 62 | View |
| Port Delivery System With Ranibizumab 100mg/mL | Participants had the Implant (prefilled with approximately 20 μL of 100-mg/mL, approximately 2 mg dose, of ranibizumab) surgically inserted in the study eye at the Day 1 visit following their randomization visit. Starting at the Month 1 visit, participants were evaluated monthly for the need for Implant refill with the 100-mg/mL formulation of ranibizumab according to their randomization as per protocol-specified refill criteria. | 1 | None | 17 | 59 | 58 | 59 | View |
Serious Events(If Any):
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| APLASTIC ANAEMIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA version 21.1 | View |
| ANGINA UNSTABLE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| ATRIAL FIBRILLATION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| ATRIAL FLUTTER | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| ATRIOVENTRICULAR BLOCK | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| CARDIAC FAILURE CONGESTIVE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| CORONARY ARTERY DISEASE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| MYOCARDIAL INFARCTION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA version 21.1 | View |
| CONJUNCTIVAL EROSION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| HYPOTONY OF EYE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| RETINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| RETINAL TEAR | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| RETINOPATHY PROLIFERATIVE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| RHEGMATOGENOUS RETINAL DETACHMENT | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| TRACTIONAL RETINAL DETACHMENT | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VISION BLURRED | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VISUAL ACUITY REDUCED | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VITREOUS HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| GASTROINTESTINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| GASTROOESOPHAGEAL REFLUX DISEASE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| HIATUS HERNIA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| CHEST PAIN | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA version 21.1 | View |
| CHOLECYSTITIS | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA version 21.1 | View |
| CHOLECYSTITIS ACUTE | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA version 21.1 | View |
| BACTERAEMIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| BRONCHITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| CELLULITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| DIVERTICULITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| ENDOPHTHALMITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| GASTROENTERITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| INFLUENZA | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| PNEUMONIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| POSTOPERATIVE WOUND INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| SEPSIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| URINARY TRACT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| BRAIN CONTUSION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| CERVICAL VERTEBRAL FRACTURE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| CONJUNCTIVAL FILTERING BLEB LEAK | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| CONJUNCTIVAL RETRACTION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| FALL | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| FRACTURE DISPLACEMENT | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| HIP FRACTURE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| HYPHAEMA | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| ILIOTIBIAL BAND SYNDROME | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| OCULAR PROCEDURAL COMPLICATION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| PERIPROSTHETIC FRACTURE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| SKULL FRACTURED BASE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| SUBDURAL HAEMATOMA | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| UPPER LIMB FRACTURE | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| WOUND SECRETION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| INTRAOCULAR PRESSURE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA version 21.1 | View |
| WEIGHT DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA version 21.1 | View |
| DEHYDRATION | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA version 21.1 | View |
| DIABETES MELLITUS | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA version 21.1 | View |
| INTERVERTEBRAL DISC DISORDER | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| ADENOCARCINOMA GASTRIC | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA version 21.1 | View |
| BREAST CANCER RECURRENT | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA version 21.1 | View |
| LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA version 21.1 | View |
| PANCREATIC CARCINOMA | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA version 21.1 | View |
| CAROTID ARTERY STENOSIS | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| CEREBROVASCULAR ACCIDENT | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| DIZZINESS | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| HYPERTENSIVE ENCEPHALOPATHY | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| MIGRAINE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| PRESYNCOPE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| SUBARACHNOID HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| TRANSIENT ISCHAEMIC ATTACK | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| DEVICE DISLOCATION | SYSTEMATIC_ASSESSMENT | Product Issues | MedDRA version 21.1 | View |
| DEVICE MALFUNCTION | SYSTEMATIC_ASSESSMENT | Product Issues | MedDRA version 21.1 | View |
| ACUTE KIDNEY INJURY | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA version 21.1 | View |
| HAEMATURIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA version 21.1 | View |
| PROSTATOMEGALY | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA version 21.1 | View |
| ACUTE RESPIRATORY FAILURE | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| LUNG CONSOLIDATION | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| PULMONARY EMBOLISM | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| RESPIRATORY DISORDER | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| AORTIC STENOSIS | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA version 21.1 | View |
| FEMORAL ARTERY ANEURYSM | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA version 21.1 | View |
| HYPERTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA version 21.1 | View |
| HYPOTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA version 21.1 | View |
Other Events(If Any):
Other Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| CHOROIDAL NEOVASCULARISATION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CONJUNCTIVAL BLEB | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CONJUNCTIVAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CONJUNCTIVAL HYPERAEMIA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CONJUNCTIVAL OEDEMA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CORNEAL OEDEMA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| DERMATOCHALASIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| DIPLOPIA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| DRY EYE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYE IRRITATION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYE PAIN | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYELIDS PRURITUS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| FOREIGN BODY SENSATION IN EYES | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| IRIDOCYCLITIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| IRITIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| LACRIMATION INCREASED | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| MACULAR DEGENERATION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| NEOVASCULAR AGE-RELATED MACULAR DEGENERATION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| OCULAR HYPERAEMIA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| PHOTOPHOBIA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| POSTERIOR CAPSULE OPACIFICATION | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| PUNCTATE KERATITIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| RETINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VISION BLURRED | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VISUAL ACUITY REDUCED | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VITREOUS DETACHMENT | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VITREOUS DISORDER | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VITREOUS FLOATERS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| VITREOUS HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CONSTIPATION | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| DIARRHOEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| GASTROOESOPHAGEAL REFLUX DISEASE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| NAUSEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 21.1 | View |
| CHEST PAIN | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA version 21.1 | View |
| FATIGUE | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA version 21.1 | View |
| BRONCHITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| DIVERTICULITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| EAR INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| HORDEOLUM | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| INFLUENZA | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| NASOPHARYNGITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| SINUSITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| TOOTH INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| UPPER RESPIRATORY TRACT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| URINARY TRACT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 21.1 | View |
| CONTUSION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| CORNEAL ABRASION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| FALL | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| HYPHAEMA | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| PROCEDURAL PAIN | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA version 21.1 | View |
| BLOOD CHOLESTEROL INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA version 21.1 | View |
| INTRAOCULAR PRESSURE DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA version 21.1 | View |
| INTRAOCULAR PRESSURE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA version 21.1 | View |
| ARTHRALGIA | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| ARTHRITIS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| BACK PAIN | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| OSTEOARTHRITIS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| PAIN IN EXTREMITY | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| ROTATOR CUFF SYNDROME | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA version 21.1 | View |
| BASAL CELL CARCINOMA | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA version 21.1 | View |
| HEADACHE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA version 21.1 | View |
| HYPERTONIC BLADDER | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA version 21.1 | View |
| NEPHROLITHIASIS | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA version 21.1 | View |
| COUGH | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA version 21.1 | View |
| ACTINIC KERATOSIS | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA version 21.1 | View |
| HYPERTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA version 21.1 | View |
| ANTERIOR CHAMBER CELL | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| ANTERIOR CHAMBER FLARE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| BLEPHARITIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CATARACT CORTICAL | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CATARACT NUCLEAR | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYE DISCHARGE | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYELID OEDEMA | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| EYELID PTOSIS | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CATARACT | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |
| CHOROIDAL DETACHMENT | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA version 21.1 | View |